This inventor holds 1 USPTO granted patent. Top assignee: Ceskoslovenska Akademie Ved. Active years: 1985.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1985
Title: Petr Simek: Innovator in Neurohypophysial Hormones
Introduction
Petr Simek is a notable inventor based in Prague, Czech Republic. He has made significant contributions to the field of neuropharmacology through his innovative research and patents. His work focuses on the development of analogs of neurohypophysial hormones, which have important implications for biological activities.
Latest Patents
Petr Simek holds a patent for "Analogs of neurohypophysial hormones with inhibition effects." This invention pertains to analogs of neurohypophysial hormones that exhibit inhibition effects, characterized by the chemical formula I ##STR1##. In this formula, A can be CH.sub.3 CO or H, V represents a residue of penicillamine or cysteine, B is CH.sub.3 or H, X is a residue of isoleucine or phenylalanine, Y is a residue of penicillamine or cysteine, and Z is a residue of leucine or lysine. These analogs demonstrate inhibition effects towards certain biological activities of neurohypophysial hormones. Petr Simek has 1 patent to his name.
Career Highlights
Petr Simek is affiliated with the Czech Academy of Sciences, where he conducts his research and development work. His career has been marked by a commitment to advancing the understanding of neurohypophysial hormones and their potential applications in medicine.
Collaborations
Petr has collaborated with esteemed colleagues such as Tomislav Barth and Frantisek Brtnik. These partnerships have enriched his research and contributed to the advancement of knowledge in the field.
Conclusion
Petr Simek is a distinguished inventor whose work on neurohypophysial hormones has the potential to impact various biological applications. His innovative approach and dedication to research continue to inspire advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
